Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of

来源 :Journal of Pharmaceutical Analysis | 被引量 : 0次 | 上传用户:ysgmxh
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Cetuximab(CTX) is a potent chimeric mouse/human monoclonal antibody(mAb) approved worldwide for treatment of metastatic colorectal cancer. Among the various biological and physical analyses performed for full study on this biopharmaceutic, the determination of the concentration preparations throughout manufacturing and subsequent handling in hospital is particularly relevant. In the present work, the study and validation of a method for quantifying intact CTX by reverse-phase high-performance liquid chromatography with diode array detection((RP)HPLC/DAD) is presented. With that end,we checked the performance of a chromatographic method for quantifying CTX and conducted a study to validate the method as stability-indicating in accordance with the International Conference on Harmonization guidelines(ICH) for biotechnological drugs; therefore, we evaluated linearity, accuracy, precision, detection and quanti fication limits, robustness and system suitability. The speci ficity of the method and the robustness of the mAb formulation against external stress factors were estimated by comprehensive chromatographic analysis by subjecting CTX to several informative stress conditions. As demonstrated, the method is rapid, accurate, and reproducible for CTX quantification. It was also successfully used to quantify CTX in a long-term stability study performed under hospital conditions. Among the various biological and physical analyzes performed for full study on this biopharmaceutic, the determination of the concentration of product throughout manufacturing and subsequent In the present work, the study and validation of a method for quantifying intact CTX by reverse-phase high-performance liquid chromatography with diode array detection ((RP) HPLC / DAD) presented. With that end , we checked the performance of a chromatographic method for quantifying CTX and conducted a study to validate the method as stability-indicating in accordance with the International Conference on Harmonization guidelines (ICH) for biotechnological drugs; therefore, we evaluated linearity, accuracy, precision, detection and quanti fication limits, robustness and system suitability. The speci ficity of the metho d and the robustness of the mAb formulation against external stress factors were estimated by full chromatographic analysis by subjecting CTX to several informative stress conditions. CTX in a long-term stability study performed under hospital conditions.
其他文献
目的 探讨基于知信行理念的健康管理在老年糖尿病患者中的临床价值.方法 选择2018年3月至2019年2月就诊的老年糖尿病患者72例进行研究,随机分为对照组与观察组各36例,对照组
We reported here the first known case of natural infection of a lion(Panthera leo-Linnaeus,1738) with Leishmania(Leithmania) chagasi(L.chagasi) in Brazil.The sp
A simple and high throughput method was developed and validated for simultaneous determination of valproic acid and its two toxicant ene-metabolites, 2-enevalpr
Plasmodium falciparum(P.falciparum) is responsible for the majority of life-threatening cases of human malaria,causing 1.5-2.7 million annual deaths.The global
目的:探析乳腺癌术后化疗患者采取综合护理行为干预的临床价值.方法:选择2017年1月-2017年8月本院乳腺癌术后化疗患者60例,遵照双盲法分组标准均分为参照组、干预组,前者采取
1例65岁男性患者因上呼吸道感染自行口服连花清瘟胶囊4粒,3次/d。第2次用药后出现颈部水肿,随后发展为面部水肿,颈部淋巴结肿大。实验室检查:ALT 219 U/L,AST 106 U/L,γ-GT 312 U/L,ALP 223 U/L,蛋白总量65 g/L,白蛋白33 g/L,白蛋白/球蛋白比值(A/G)1.02,TBil 14.4 μmol/L,DBil 6.7 μmol/L,CRP 110
AIM: To explore the role of transforming growth factorbeta1 (TGF-β1)-smad signal transduction pathway in patients with hepatocellular carcinoma.METHODS: Thirty
Sludge dewatering and treatment may cost as much as the wastewater treatment. Usually large proportion of the pollutants in wastewater is organic. They are atta
目的观察白内障及增生性糖尿病性视网膜病变(PDR)联合手术的效果。方法回顾性分析2015年2月至2018年1月该院眼科白内障伴PDR 142例(142眼)的临床资料。患者随机分为两组:采用超声乳化人工晶状体植入联合玻璃体切除术者为A组(72眼);采用玻璃体切除联合晶状体切除及人工晶状体植入者为B组(70眼)。结果两组之间术前视力差异无统计学意义(P=0.453),而术后视力差异有统计学意义(Z=-
目的探讨雷公藤多苷为主三联药物方案治疗糖尿病肾病Ⅲ期临床效果及安全性。方法选取糖尿病肾病Ⅲ期患者160例,采用随机数字表法分为对照组和治疗组,每组80例。对照组患者采用坎地沙坦联合百令胶囊口服治疗;治疗组患者则在此基础上加用雷公藤多苷口服治疗。比较两组患者的临床疗效,治疗前后肾功能指标、肝功能指标、血常规水平和不良反应发生率等。结果对照组和治疗组患者临床治疗总有效率分别为53.75%(43/80)